These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16013637)

  • 1. The value of ultrasonography and computerized tomography in estimating the histopathological severity of nonalcoholic steatohepatitis.
    Ataseven H; Yildirim MH; Yalniz M; Bahcecioglu IH; Celebi S; Ozercan IH
    Acta Gastroenterol Belg; 2005; 68(2):221-5. PubMed ID: 16013637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between advanced oxidation protein products (AOPP) and biochemical and histopathological findings in patients with nonalcoholic steatohepatitis.
    Ozenirler S; Erkan G; Konca Degertekin C; Ercin U; Cengiz M; Bilgihan A; Yilmaz G; Akyol G
    J Dig Dis; 2014 Mar; 15(3):131-6. PubMed ID: 24528633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.
    Harrison SA; Torgerson S; Hayashi PH
    Am J Gastroenterol; 2003 Sep; 98(9):2042-7. PubMed ID: 14499785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle.
    Kitajima Y; Hyogo H; Sumida Y; Eguchi Y; Ono N; Kuwashiro T; Tanaka K; Takahashi H; Mizuta T; Ozaki I; Eguchi T; Kimura Y; Fujimoto K; Anzai K;
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1507-14. PubMed ID: 23577962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation.
    Oliva MR; Mortele KJ; Segatto E; Glickman JN; Erturk SM; Ros PR; Silverman SG
    J Comput Assist Tomogr; 2006; 30(1):37-43. PubMed ID: 16365570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of ultrasonographic examination for nonalcoholic steatohepatitis in morbidly obese patients undergoing laparoscopic bariatric surgery.
    Liang RJ; Wang HH; Lee WJ; Liew PL; Lin JT; Wu MS
    Obes Surg; 2007 Jan; 17(1):45-56. PubMed ID: 17355768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis.
    Koruk M; Tayşi S; Savaş MC; Yilmaz O; Akçay F; Karakök M
    Turk J Gastroenterol; 2003 Mar; 14(1):12-7. PubMed ID: 14593532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Pentraxin 3 Differentiates Nonalcoholic Steatohepatitis (NASH) from Non-NASH.
    Boga S; Koksal AR; Alkim H; Yilmaz Ozguven MB; Bayram M; Ergun M; Sisman G; Tekin Neijmann S; Alkim C
    Metab Syndr Relat Disord; 2015 Nov; 13(9):393-9. PubMed ID: 26367098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.
    Ribeiro PS; Cortez-Pinto H; Solá S; Castro RE; Ramalho RM; Baptista A; Moura MC; Camilo ME; Rodrigues CM
    Am J Gastroenterol; 2004 Sep; 99(9):1708-17. PubMed ID: 15330907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic findings in patients with nonalcoholic steatohepatitis.
    Tanaka N; Ichijo T; Okiyama W; Mutou H; Misawa N; Matsumoto A; Yoshizawa K; Tanaka E; Kiyosawa K
    Liver Int; 2006 Feb; 26(1):32-8. PubMed ID: 16420508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery.
    Pirvulescu I; Gheorghe L; Csiki I; Becheanu G; Dumbravă M; Fica S; Martin S; Sarbu A; Gheorghe C; Diculescu M; Copăescu C
    Chirurgia (Bucur); 2012; 107(6):772-9. PubMed ID: 23294957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients.
    Shalhub S; Parsee A; Gallagher SF; Haines KL; Willkomm C; Brantley SG; Pinkas H; Saff-Koche L; Murr MM
    Obes Surg; 2004 Jan; 14(1):54-9. PubMed ID: 14980034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive fibrosis seromarkers as a predictor of liver fibrosis in chronic hepatitis C and/or non-alcoholic steatohepatitis.
    Ahmed L; Salama H; Ahmed R; Hamdy S; Al-Akel W; Shafi SA; Mahgoub A; Hareedy A; Fathy W
    Arab J Gastroenterol; 2009 Mar; 10(1):14-20. PubMed ID: 24842131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could inflammatory markers help diagnose nonalcoholic steatohepatitis?
    Tarantino G; Conca P; Pasanisi F; Ariello M; Mastrolia M; Arena A; Tarantino M; Scopacasa F; Vecchione R
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):504-11. PubMed ID: 19318968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver function breath tests for differentiation of steatohepatitis from simple fatty liver in patients with nonalcoholic Fatty liver disease.
    Tribonias G; Margariti E; Tiniakos D; Pectasides D; Papatheodoridis GV
    J Clin Gastroenterol; 2014 Jan; 48(1):59-65. PubMed ID: 24335903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease.
    Canbakan B; Senturk H; Tahan V; Hatemi I; Balci H; Toptas T; Sonsuz A; Velet M; Aydin S; Dirican A; Ozgulle S; Ozbay G
    Acta Gastroenterol Belg; 2007; 70(3):277-84. PubMed ID: 18074737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease.
    Zelber-Sagi S; Kessler A; Brazowsky E; Webb M; Lurie Y; Santo M; Leshno M; Blendis L; Halpern Z; Oren R
    Clin Gastroenterol Hepatol; 2006 May; 4(5):639-44. PubMed ID: 16630771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI findings in nonalcoholic steatohepatitis: correlation with histopathology and clinical staging.
    Elias J; Altun E; Zacks S; Armao DM; Woosley JT; Semelka RC
    Magn Reson Imaging; 2009 Sep; 27(7):976-87. PubMed ID: 19356874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis.
    Kojima H; Sakurai S; Uemura M; Fukui H; Morimoto H; Tamagawa Y
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S61-6. PubMed ID: 17331168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.